| For: | Almeida PH, Matielo CEL, Curvelo LA, Rocco RA, Felga G, Della Guardia B, Boteon YL. Update on the management and treatment of viral hepatitis. World J Gastroenterol 2021; 27(23): 3249-3261 [PMID: 34163109 DOI: 10.3748/wjg.v27.i23.3249] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i23/3249.htm |
| Number | Citing Articles |
| 1 |
Moises Martinez-Castillo, Itzel Altamirano-Mendoza, Rafal Zielinski, Waldemar Priebe, Cristina Piña-Barba, Gabriela Gutierrez-Reyes. Collagen matrix scaffolds: Future perspectives for the management of chronic liver diseases. World Journal of Clinical Cases 2023; 11(6): 1224-1235 doi: 10.12998/wjcc.v11.i6.1224
|
| 2 |
Maheswata Moharana, Subrat Kumar Pattanayak, Fahmida Khan.
Molecular recognition of bio-active triterpenoids from
Swertia chirayita
towards hepatitis Delta antigen: a mechanism through docking, dynamics simulation, Gibbs free energy landscape
. Journal of Biomolecular Structure and Dynamics 2023; 41(24) doi: 10.1080/07391102.2023.2184173
|
| 3 |
Habiba Debbabi, Eya Chakroun, Hajer Hassine, Hela Kchir, Dhouha Cherif, Haythem Yacoub, Nadia Maamouri. Case Report: Acute hepatitis A virus infection presenting with direct antiglobulin test-negative autoimmune hemolytic anemia and α-thalassemia trait. F1000Research 2024; 13 doi: 10.12688/f1000research.156586.1
|
| 4 |
Zhengmin Wang, Nan Liu, Yongqi Li, Tianyang Li, Licong Ma, Zhongfeng Wang, Xinyang Li, Yun Dai, Tong Zhang, Zhiheng Guo, Yao Zhi, Faxiang Ma, Juan Lv, Yanhang Gao, Junqi Niu, Yang Yang, Zhengkun Tu. HBV induces immunosuppressive macrophages via metabolic and epigenetic reprogramming to facilitate the establishment of chronic persistent infection. Gut 2026; doi: 10.1136/gutjnl-2025-337367
|
| 5 |
Deepa Augustine, Arya James, K. Preethi. Coexistence of multiple sexually transmitted infections in a human immunodeficiency virus-negative individual. Journal of Skin and Sexually Transmitted Diseases 2022; 4 doi: 10.25259/JSSTD_79_2021
|
| 6 |
José Carlos R. Nascimento, Larissa F. F. Castro, Reinaldo B. Oriá, Pierluigi Toniutto. Apolipoprotein E. 2025; doi: 10.1007/978-3-031-52641-1_54-1
|
| 7 |
Meraj Ahmed, Hirdaya Hulas Nag, Pankaj Meena. Clinical approach to patients with thick wall gallbladder. Egyptian Journal of Radiology and Nuclear Medicine 2023; 54(1) doi: 10.1186/s43055-023-01137-3
|
| 8 |
Junhong Lu, Qingwen Deng, Yuehua Chen, Wenbin Liu. Impact of perceived ease of use, organizational support mechanism, and industry competitive pressure on physicians’ use of liver cancer screening technology in medical alliances. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1174334
|
| 9 |
Kunalsen Jagatdeo, Ankita Roy, Kumudini Panigrahi, Nishikanta Thatoi, Jyoti Prakash Sahoo, Basanti Kumari Pathi. Seroprevalence of Hepatitis A Virus and Hepatitis E Virus Among Patients With Acute Viral Hepatitis in a Tertiary Care Hospital: A Retrospective Study. Cureus 2026; doi: 10.7759/cureus.107739
|
| 10 |
Laboratory Medicine in Psychiatry and Behavioral Science, Second Edition. 2023; doi: 10.1176/appi.books.9781615379897.bm06
|
| 11 |
Hikaru Hayashi, Akira Shimizu, Hiroaki Motoyama, Koji Kubota, Tsuyoshi Notake, Hitoshi Masuo, Takahiro Yoshizawa, Kiyotaka Hosoda, Hiroki Sakai, Koya Yasukawa, Yuji Soejima. Safety and oncological benefits of hepatectomy for hepatocellular carcinoma in octogenarians. Asian Journal of Surgery 2023; 46(1) doi: 10.1016/j.asjsur.2022.04.074
|
| 12 |
Joo Hyun Oh, Jonghyun Lee, Eileen L. Yoon, Soung Won Jeong, Soon Sun Kim, Young Eun Chon, Sang Bong Ahn, Dae Won Jun. Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area. Cancers 2023; 16(1) doi: 10.3390/cancers16010150
|
| 13 |
Xiaolei Zhang, Fuyan Tang, Wei Shu, Dongpeng Li, Yuying Liu, Haibin Xiao, Jin Zhou, Ping Li. Small-molecule fluorescent probes for bioactive species in inflammatory disease: arthritis, pneumonia and hepatitis. The Analyst 2023; 148(21) doi: 10.1039/D3AN01289A
|
| 14 |
Areeba H. Rizvi, Mohammad A. Alutaibi, Oyedele A. Adeyi. Practical Liver Pathology. Practical Anatomic Pathology 2025; doi: 10.1007/978-3-031-97506-6_6
|
| 15 |
Ji Li, Yifeng Cheng, Yongli Pan, Xue Liu, Xiaoying Gan, Xiaoqing Pan, Yali Chen. The Economic Impact of Cirrhosis and Other Chronic Liver Diseases on Global, Regional, and National Economies. Clinical and Translational Gastroenterology 2026; 17(7) doi: 10.14309/ctg.0000000000000989
|
| 16 |
Seung-mo Kim, Yu-ri Lee, Na-kyung Cho, Hong-sik Choi, Kyung-soon Kim. Herbal Medicine for the Treatment of Viral Hepatitis B and C: A Systematic Review of Randomized Controlled Trials. The Journal of Internal Korean Medicine 2021; 42(4) doi: 10.22246/jikm.2021.42.4.455
|
| 17 |
Ka‐Ying Wong, Zhenyu Nie, Man‐Sau Wong, Yang Wang, Juewen Liu. Metal–Drug Coordination Nanoparticles and Hydrogels for Enhanced Delivery. Advanced Materials 2024; 36(26) doi: 10.1002/adma.202404053
|
| 18 |
Janitha M. Unagolla, Subarna Das, Riley Flanagan, Marin Oehler, Jyothi U. Menon. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives. International Journal of Pharmaceutics 2024; 660 doi: 10.1016/j.ijpharm.2024.124381
|
| 19 |
Amol D. Gholap, Pankaj R. Khuspe, Sagar R. Pardeshi, Md Jasim Uddin, Ushasi Das, Navnath T. Hatvate, Satish Rojekar, Prabhanjan Giram, Mohammad Khalid, Yahya E. Choonara, Md. Faiyazuddin. Achieving Optimal Health With Host‐Directed Therapies (HDTs) in Infectious Diseases—A New Horizon. Advanced Therapeutics 2025; 8(4) doi: 10.1002/adtp.202400169
|
| 20 |
Chenggong Zhu, Zhen Xun, Ruijie Fu, Qunfang Huang, Qishui Ou, Yunlei Xianyu, Can Liu. Nanoparticle-driven biosensors for diagnosis of viral hepatitis. TrAC Trends in Analytical Chemistry 2024; 180 doi: 10.1016/j.trac.2024.117985
|
| 21 |
Sumaiah J. Alarfaj, Abdullah Alzahrani, Anfal Alotaibi, Malak Almutairi, Mashael Hakami, Njood Alhomaid, Noori Alharthi, Ghazwa B. Korayem, Abdullah Alghamdi. The effectiveness and safety of direct-acting antivirals for hepatitis C virus treatment: A single-center experience in Saudi Arabia. Saudi Pharmaceutical Journal 2022; 30(10) doi: 10.1016/j.jsps.2022.07.005
|
| 22 |
Daniel Sepúlveda-Crespo, Salvador Resino. From Management to Cure: The Shifting Paradigm in HIV and Chronic Viral Hepatitis. Pharmaceuticals 2025; 18(7) doi: 10.3390/ph18071034
|
| 23 |
Vitória Machado Krüger, Ana Carolina Almeida da Silva, Marlise Antunes Grahl, Matheus dos Anjos Catasblancas, Maiara Lenise Lütz, João Pedro Stepan Wagner, Alexandre Lemos da Silva, Eduardo Viegas da Silva, Pedro Augusto Crespo da Silva. Factors influencing hepatitis C treatment initiation in a high-prevalence Brazilian state. Cadernos de Saúde Pública 2026; 42 doi: 10.1590/0102-311xen233025
|
| 24 |
Eliott S. Kim, Evan E. Afshin, Ebby Elahi. The lowly chalazion. Survey of Ophthalmology 2023; 68(4) doi: 10.1016/j.survophthal.2022.11.002
|
| 25 |
Avijit Biswal, Maheswata Moharana. Natural Compounds and Alternative Therapies for Hepatitis. 2026; doi: 10.1002/9781394466573.ch1
|
| 26 |
Habiba Debbabi, Eya Chakroun, Hajer Hassine, Hela Kchir, Dhouha Cherif, Haythem Yacoub, Nadia Maamouri. Case Report: Acute hepatitis A virus infection presenting with direct antiglobulin test-negative autoimmune hemolytic anemia and α-thalassemia trait. F1000Research 2025; 13 doi: 10.12688/f1000research.156586.2
|
| 27 |
Shuaibu Hudu, Abdulgafar Jimoh, Kasimu Ibrahim, Ahmed Alshrari. Hepatitis B Therapeutic Vaccine: A Patent Review. Pharmaceuticals 2022; 15(12) doi: 10.3390/ph15121542
|
| 28 |
Vanessa Zhu, Jürgen Burhenne, Johanna Weiss, Mathias Haag, Ute Hofmann, Matthias Schwab, Stephan Urban, Gerd Mikus, David Czock, Walter E. Haefeli, Antje Blank. Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1128547
|
| 29 |
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6) doi: 10.3390/microorganisms12061035
|
| 30 |
Daisuke Usuda, Yuki Kaneoka, Rikuo Ono, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge, Riki Sakurai, Kenji Kawai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou, Sakurako Ito, Kentaro Mishima, Akihiko Kondo, Keiko Mizuno, Hiroki Takami, Takayuki Komatsu, Tomohisa Nomura, Manabu Sugita. Current perspectives of viral hepatitis. World Journal of Gastroenterology 2024; 30(18): 2402-2417 doi: 10.3748/wjg.v30.i18.2402
|
| 31 |
Colin Fitzpatrick, Shaira Doherty, Sabina George, Daniel Richardson. Hepatitis E in men who have sex with men: a systematic review. Frontline Gastroenterology 2024; 15(6) doi: 10.1136/flgastro-2024-102797
|
| 32 |
Yan Li, Jun Zhou, Tianliang Li. Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.879817
|
| 33 |
Rui Li, Mingwang Shen, Jason J. Ong, Fuqiang Cui, Wenyi Hu, Polin Chan, Zhuoru Zou, Shu Su, Hangting Liu, Lei Zhang, Wai-Kay Seto, William C.W. Wong. Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies. JHEP Reports 2023; 5(10) doi: 10.1016/j.jhepr.2023.100833
|
| 34 |
Abolfazl Jafarı-sales, Parniya Nouri-dizaj, Soheyla Hosseyni-nasababad, Sanam Karzar-torkambour, Aylin Golestani, Zahra Ghahremani, Mehrdad Pashazadeh, Sara Naebi. Hepatitis C Virus (HCV) and Hepatitis D Virus (HDV): Divergent Pathways to Hepatocellular Carcinoma (HCC) and Therapeutic Strategies. Archives of Current Medical Research 2026; 7(1) doi: 10.47482/acmr.1714274
|
| 35 |
Cheng Wang, Cheng Ma, Lihong Gong, Yuqin Guo, Ke Fu, Yafang Zhang, Honglin Zhou, Yunxia Li. Macrophage Polarization and Its Role in Liver Disease. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.803037
|
| 36 |
Tao Sun, Shilin Xiao, Miaomiao Wang, Qian Xie, Liang Zhang, Mingfu Gong, Dong Zhang, Chunyu Zhou. Reactive Oxygen Species Scavenging Nanozymes: Emerging Therapeutics for Acute Liver Injury Alleviation. International Journal of Nanomedicine 2023; doi: 10.2147/IJN.S435544
|
| 37 |
Nadera Altork, Michele P. Fischer, Lukman Cheraghvandi, Arul M. Thomas. Ribavirin Treatment in Acute HEV-Induced Liver Injury in a Healthy US Female: A Case Report. Case Reports in Gastroenterology 2025; 19(1) doi: 10.1159/000546235
|
| 38 |
Jenniffer Romina Cañarte Murillo , Frised Geovanny Mera Zambrano, Emily Dayana Mite Ramírez, Carlos Alberto Moreira Macías, Madeleyne Janeth Pinargote Moreira. Impacto del tratamiento antiviral en la progresión del daño hepático a nivel de América Latina. Arandu UTIC 2025; 12(1) doi: 10.69639/arandu.v12i1.772
|
| 39 |
Francesco Bruno, Paolo Abondio, Rossella Bruno, Leognano Ceraudo, Ersilia Paparazzo, Luigi Citrigno, Donata Luiselli, Amalia C. Bruni, Giuseppe Passarino, Rosanna Colao, Raffaele Maletta, Alberto Montesanto. Alzheimer’s disease as a viral disease: Revisiting the infectious hypothesis. Ageing Research Reviews 2023; 91 doi: 10.1016/j.arr.2023.102068
|
| 40 |
Wesley D Figg, David L Crawford, Tristen N Taylor, Mayar Al Mohajer. Rare Diagnostic and Clinical Manifestations in an Acute Hepatitis A Infection: A Case Report. Cureus 2022; doi: 10.7759/cureus.29194
|
| 41 |
José Carlos R. Nascimento, Larissa F. F. Castro, Reinaldo Oriá, Pierluigi Toniutto. Apolipoprotein E. 2026; doi: 10.1007/978-3-031-96089-5_54
|
| 42 |
Yu Zhang, Dongsheng Wu, Xiaoling Tian, Bin Chen. From hepatitis B virus infection to acute‐on‐chronic liver failure: The dynamic role of hepatic macrophages. Scandinavian Journal of Immunology 2024; 99(3) doi: 10.1111/sji.13349
|
| 43 |
Chengqian Feng, Jingrong Shi, Yunfu Chen, Sisi Chen, Jianping Cui, Jun Zhang, Xiaowen Zheng, Yaping Wang, Feng Li. A hepatitis B virus-free cccDNA-producing stable cell for antiviral screening. Antiviral Research 2025; 237 doi: 10.1016/j.antiviral.2025.106143
|
| 44 |
Luigi Santacroce, Lucrezia Bottalico, Ioannis Alexandros Charitos, Francesca Castellaneta, Elona Gaxhja, Skender Topi, Raffaele Palmirotta, Emilio Jirillo. Exploitation of Natural By-Products for the Promotion of Healthy Outcomes in Humans: Special Focus on Antioxidant and Anti-Inflammatory Mechanisms and Modulation of the Gut Microbiota. Antioxidants 2024; 13(7) doi: 10.3390/antiox13070796
|
| 45 |
Lauren A. Newman, Kate Muller, Andrew Rowland. Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases. Cellular and Molecular Life Sciences 2022; 79(5) doi: 10.1007/s00018-022-04256-8
|
| 46 |
Carlos Eduardo Collazo Pontes, Jorge Lima de Magalhães. Digital Knowledge in Modern Education Management. 2026; doi: 10.4018/979-8-2600-3460-6.ch006
|
| 47 |
Hind A. Beydoun, Jack Tsai. Screening rates for hepatitis B and C among low‐income US veterans: Data from the National Veteran Homeless and Other Poverty Experiences Study. Journal of Viral Hepatitis 2024; 31(10) doi: 10.1111/jvh.13981
|
| 48 |
Daniel Richardson, Holly D Mitchell, Claire Jenkins, Lewis C E Mason, Michael Ewens, Lucy Rabuszko, Callum Chessell, Deborah Williams, Colin Fitzpatrick, Omar Kadhim Mohammed, Jason Zucker, Henry JC de Vries, Kate S Baker. Sexually transmissible infections affecting the gastrointestinal tract: what gastroenterologists and hepatologists need to know. Frontline Gastroenterology 2025; doi: 10.1136/flgastro-2025-103321
|
| 49 |
Abeer Shahzad, Muhammad Bilal Islam, Hira Anas Khan, Zoaib Habib Tharwani, Abdullah Malikzai. Hepatitis B and C in Pakistan: is there hope for a better treatment?. International Journal of Surgery: Global Health 2023; 6(4) doi: 10.1097/GH9.0000000000000216
|
| 50 |
Monica Centa, Christelle Thermidor, Maria Isabel Fiel, Konstantina Alexandropoulos. Profiling of mouse and human liver diseases identifies targets for therapeutic treatment of autoimmune hepatitis. Clinical Immunology 2023; 256 doi: 10.1016/j.clim.2023.109807
|
| 51 |
Aslıhan Demirel, Suleyman Uraz, Zeynep Deniz, Ebubekir Daglilar, Omer Basar, Veysel Tahan, Resat Ozaras. Epidemiology of hepatitis D virus infection in Europe: Is it vanishing?. Journal of Viral Hepatitis 2024; 31(2) doi: 10.1111/jvh.13899
|
| 52 |
Yuanqiong Chen, Chao Zhang, Zhuoru Zou, Weijun Hu, Dan Zhang, Sidi Zhao, Shaobai Zhang, Qian Wu, Lei Zhang. Hepatitis E Vaccination Preferences and Willingness-to-Pay Among Residents: A Discrete Choice Experiment Analysis. Vaccines 2025; 13(9) doi: 10.3390/vaccines13090906
|
| 53 |
Pengyu Luo, Yuna Tang, Nan Chen, Pei Liu, Jing Wang, Yuchen Fan, Huihui Liu, Kai Wang. USP21 is involved in the development of chronic hepatitis B by modulating the immune microenvironment. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-02502-w
|
| 54 |
Nura Adam Mohamed, Farah Atifi, Zineb Ourradi, Sergio Crovella, Moutaz Derbala, Hadi M. Yassine, Ejaife O. Agbani, Yahye Merhi, Younes Zaid, Haissam Abou-Saleh. Nanoparticle approaches for hepatitis therapy and clinical translation. Discover Nano 2026; 21(1) doi: 10.1186/s11671-026-04450-8
|
| 55 |
Hongmei Wu, Li Liu, Jialin Qu, Chunrui Wang, Xiaofeng Shi, Yu Lei. Chronic active Epstein-Barr virus infection with reinfection of SARS-CoV-2: a case report. Virology Journal 2024; 21(1) doi: 10.1186/s12985-024-02418-7
|
| 56 |
Clinical diagnosis of viral hepatitis: Current status and future strategies. Diagnostic Microbiology and Infectious Disease 2024; 108(3) doi: 10.1016/j.diagmicrobio.2023.116151
|